studentFaculty of Medicine Université LavalQuébec, Quebec, Canada
Maternal docosahexaenoic acid supplementation for neurodevelopmental outcomes of breastfed very preterm infants: a follow-up at 5 years’ corrected age of a randomized clinical trial (MOBYDIckPS)
Monday, May 6, 20241:15 PM – 1:30 PM ET
Disclosure(s): I do not have any relevant financial / non-financial relationships with any proprietary interests.